OPTIMISTICC

Opportunity To Investigate the Microbiome’s Impact on Science and Treatment In Colorectal Cancer

We are an international team working together to understand the colorectal cancer microbiome: what it is, how it is associated with cancer, and what treatments will affect the microbiome to promote health.

Our objectives are to:

Map the colorectal cancer microbiome
Develop microbiome-targeted therapies for colorectal cancer
Share and disseminate our findings

Dr. Josep Tabernero is appointed Board Chairman of Cancer Core Europe

Team OPTIMISTICC congratulates Dr. Josep Tabernero, director of Vall d’Hebron Institute of Oncology (VHIO), on his appointment as chairman of Cancer Core Europe (CCE). CCE is an association of seven premier cancer centers in Europe. We look forward to new successes in cancer care and cancer research under Dr. Tabernero’s leadership.

We are our microbes!

Watch the video that explains what the microbiome is and the importance in colorectal cancer. This video was a collaboration between team OPTIMISTICC patient advocates and researchers. Get ready to learn and ENJOY!

Watch the OPTIMISTICC Webinar

A series of informal conversations between the OPTIMISTICC researchers and patient advocates discussing the role of the gut microbiome in human health and disease and its association with colorectal cancer.

This webinar is a collaboration between Colorectal Cancer Canada, the OPTIMISTICC team, and the Cancer Research UK Cancer Grand Challenges.

Learn More